Whether you are a competitive athlete or an older adult, strong bones are essential—not only for movement, but also for ...

New gene therapy improves the life of 18-year-old with Sickle Cell Disease which affects 5,000 New Jersey residents living ...

Sanofi's rilzabrutinib earns its fourth orphan drug status from the FDA, this time targeting sickle cell disease.

Researchers have discovered a breakthrough link between organ failure and long Covid after overcoming contentious Covid-era ...

Paris: Sanofi has received orphan drug designation from the US Food and Drug Administration (FDA) for rilzabrutinib, a novel, ...

According to reports, an estimated 7.74 million people lived with sickle cell disease in 2021. Sickle cell anaemia can be a ...